Extensior 1mg Injection
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
Extensior 1mg Injection
contains Semaglutide 1mg per weekly dose, manufactured by Zydus. This is the maximum therapeutic dose in the Extensior injectable range, delivering superior HbA1c reduction (~1.8%) and greater weight loss than lower doses. Equivalent to Ozempic 1mg at a fraction of the branded price, Extensior 1mg is the preferred long-term option for patients requiring maximum GLP-1 efficacy in the standard diabetes dose range.
Benefits:
- Superior HbA1c reduction (~1.8%) and approximately 5% body weight loss versus the 0.5mg dose
- Demonstrated 26% reduction in MACE risk in the SUSTAIN-6 cardiovascular outcomes trial
- Maximum dose in the Extensior injectable range for optimal diabetes management
- Once-weekly injection delivering consistent sustained pharmacokinetics
- Manufactured by Zydus — India's globally accredited pharmaceutical company
How It Works:
At 1mg, semaglutide achieves near-maximal GLP-1 receptor engagement within the standard approved diabetes dose range. Central appetite suppression is robust, gastric emptying is substantially delayed, and glucose-dependent insulin secretion is powerfully amplified. These combined effects drive sustained reductions in blood glucose and body weight with additional cardiovascular, lipid, and blood pressure benefits.
Dosage and Administration:
Inject 1mg subcutaneously once weekly after at least 4 weeks on the 0.5mg Extensior dose. Administer into the abdomen, thigh, or outer upper arm. Rotate injection sites. This is the maximum dose in the Extensior injection range.
Side Effects:
Common: nausea, diarrhoea, vomiting, constipation, decreased appetite, abdominal pain. Uncommon: fatigue, dizziness, elevated resting heart rate. Serious: pancreatitis, gallbladder disease, diabetic retinopathy worsening.
Precautions:
Contraindicated in personal or family history of medullary thyroid carcinoma or MEN2. Monitor patients with diabetic retinopathy during rapid HbA1c improvement. Adjust concurrent insulin and sulphonylurea doses as needed.
Extensior Dosage Comparison Guide
| Strength | Best For | Onset | Duration | Link |
|---|---|---|---|---|
| 0.25mg | Lower strength option | 2–4 wks | Weekly | View → |
| 0.5mg | Popular strength option | 2–4 wks | Weekly | View → |
| 1mg | Maximum strength variant | 2–4 wks | Weekly | Current |
* Always consult your doctor before changing your dosage. This information is for educational reference only.
Frequently Asked Questions
Q1: What is Extensior 1mg Injection used for?
Extensior 1mg is the maximum dose in the Extensior injectable semaglutide range by Zydus, prescribed for adults with type 2 diabetes requiring optimal glycaemic control and superior weight loss after completing the titration schedule.
Q2: How does Extensior 1mg compare to Ozempic 1mg?
Extensior 1mg contains the same semaglutide at the same dose as Ozempic 1mg. As a Zydus-manufactured equivalent, it delivers equivalent GLP-1 receptor agonist effects — HbA1c reduction, weight loss, cardiovascular benefit — at substantially lower cost.
Q3: Why is Extensior 1mg priced lower than Extensior 0.5mg?
Injection pricing for branded generic products can vary based on production batch economics, vial formulation, and market positioning rather than strict per-mg drug content. The 1mg pen remains fully equivalent in clinical efficacy to other semaglutide 1mg products.
Q4: Does Extensior 1mg reduce cardiovascular risk?
The SUSTAIN-6 trial demonstrated that semaglutide 1mg reduced major adverse cardiovascular events by 26% in adults with established cardiovascular disease and type 2 diabetes. Extensior 1mg, as an equivalent dose, is expected to confer the same benefit.
Q5: Can Extensior 1mg be used for weight management without diabetes?
While the 1mg dose is approved for type 2 diabetes, prescribers may use it off-label for weight management. For dedicated obesity therapy, higher doses (1.7mg or 2.4mg from other Zydus range products) are more appropriate.
Customer Reviews
Dr. Maria Santos
Australia · 3 weeks ago
“Good quality product. Shipping was fast and handled with care. Would recommend for professional hospital procurement.”
Michael K.
USA · 2 months ago
“Fast international shipping and professional packaging. Product was exactly as described. Highly recommend this supplier.”
Dr. James Wilson
USA · 1 week ago
“Excellent product quality. Arrived well-packaged with proper cold chain maintained throughout transit. Will order again.”
Priya Sharma
India · 1 month ago
“Prompt response from the team and smooth ordering process. Medicine arrived in original sealed packaging as expected.”
FirstCare Clinic
Canada · 3 months ago
“Good value for bulk procurement orders. Communication was clear and the shipment arrived within the estimated timeframe.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.